Free Newsletter
BMS plans to remodel its downsized Syracuse plant
Bristol-Myers Squibb plans to demolish half of the 118 buildings at its East Syracuse operation in a facelift that reflects the changes that have occurred inside the drug plant. Report
More stories about Bristol-Myers Squbb
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: